Berkshire Bank’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$259K Sell
3,308
-193
-6% -$15.6K 0.05% 141
2026
Q1
$303K Hold
3,501
0.06% 134
2025
Q4
$336K Sell
3,501
-60
-2% -$5.83K 0.07% 124
2025
Q3
$339K Buy
3,561
+11
+0.3% +$1.01K 0.07% 124
2025
Q2
$309K Buy
3,550
+335
+10% +$28.4K 0.07% 132
2025
Q1
$289K Buy
3,215
+357
+12% +$31.9K 0.07% 131
2024
Q4
$228K Buy
2,858
+92
+3% +$7.96K 0.05% 150
2024
Q3
$249K Buy
+2,766
New +$233K 0.06% 141

Other funds holding MDT

Berkshire Bank's MDT Position: Q2 2026 in Review

Berkshire Bank reduced its Medtronic (MDT) stake by 5.5% in Q2 2026, selling an estimated $15.6K and leaving 3,308 shares worth $259K. The position accounts for 0.05% of the portfolio, ranked #141.

Berkshire Bank first reported a position in MDT in Q3 2024 and has held it in 8 quarters since. The position peaked at $339K in Q3 2025. 1,015 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Berkshire Bank held 3,308 shares of Medtronic worth $259K as of Q2 2026.
  • Berkshire Bank sold 193 Medtronic shares in Q2 2026, an estimated $15.6K.
  • Medtronic made up 0.05% of Berkshire Bank's portfolio in Q2 2026, its #141 holding.
  • Berkshire Bank first reported a position in Medtronic in Q3 2024 and has held it in 8 quarters since.
  • Berkshire Bank's Medtronic position peaked at $339K in Q3 2025.
  • 1,015 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Berkshire Bank's 13F filing for Q2 2026, filed 8 Jul 2026.